| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.062 | 0.4 |